Scabies Management Outcomes: Identification of Risk Factors for Treatment Success or Failure
Dermatology Practical & Conceptual · 30.04.2025 · 15 (2) · 5077
DOI: 10.5826/dpc.1502a5077 ↗Kurz gefasst
Fachartikel in der Zeitschrift Dermatology Practical & Conceptual, online erschienen am 30.04.2025. Verfasst von Vanessa Azzolina und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology and Venereology, Medical Center, University of Freiburg, Freiburg, Germany. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Introduction
Scabies is a parasitic infectious skin disease classified as a neglected tropical disease by the World Health Organization in 2017. Currently, it is becoming a major challenge in high-income countries, with rapidly rising incidence and increasing reports about treatment failure.
Objectives
Factors that are associated with treatment failure or success were evaluated.
Methods
This non-interventional prospective observational study was conducted as a questionnaire survey at the Department of Dermatology and Venereology of the University of Freiburg from January to November 2023. Patients that still suffered from scabies 2–6 weeks after medical treatment were classified as “failure”; those who were free of scabies belonged to the success group.
Results
Of 102 participants, with a mean age of 34.4 ± 17.3 years (male: 60.4%), 77 (75.5%) were assigned to the success and 25 (24.5%) to the failure group. A larger proportion of the latter was clinically more severely affected, applied permethrin monotherapy, did not undertake special decontamination measures, but used alcohol as a disinfectant. Treatment success was associated with an additional systemic treatment, a repeated intake of ivermectin, and intensified decontamination measures such as storage of clothes in plastic bags for four days or vacuum cleaning of car seats.
Conclusions
Our findings indicate that a consistent second-dose administration of ivermectin and refraining from permethrin monotherapy may be advisable.
Autor:innen und Institutionen
- Department of Dermatology and Venereology, Medical Center, University of Freiburg, Freiburg, Germany.
- Department of Dermatology and Allergy, Technical University of Munich, School of Medicine and Health, Munich, Germany.
- Division of Dermatology and Venereology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
Zitieren
APA
Azzolina, V., Schauer, F., Pilz, J. F., Zink, A., Eyerich, K., & Pilz, A. C. (2025). Scabies Management Outcomes: Identification of Risk Factors for Treatment Success or Failure. Dermatology Practical & Conceptual, 15(2), 5077. https://doi.org/10.5826/dpc.1502a5077
Vancouver
Azzolina V, Schauer F, Pilz JF, Zink A, Eyerich K, Pilz AC. Scabies Management Outcomes: Identification of Risk Factors for Treatment Success or Failure. Dermatology Practical & Conceptual. 2025;15(2):5077. doi:10.5826/dpc.1502a5077
BibTeX
@article{Azzolina2025,
author = {Azzolina, Vanessa and Schauer, Franziska and Pilz, Julia Felicitas and Zink, Alexander and Eyerich, Kilian and Pilz, Anna Caroline},
title = {Scabies Management Outcomes: Identification of Risk Factors for Treatment Success or Failure},
journal = {Dermatology Practical & Conceptual},
year = {2025},
volume = {15},
number = {2},
pages = {5077},
doi = {10.5826/dpc.1502a5077}
}
EUVIMED